semaglutide cardiovascular outcome
Tirzepatide Beats Semaglutide In Prescription Weight Loss
Tirzepatide lowers major adverse cardiovascular events by about 18% more than semaglutide, making it the stronger heart-protective choice, though semaglutide still delivers the greatest weight loss. Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health